Volume 148, Issue 4 pp. 551-561

Myeloma cell-induced disruption of bone remodelling compartments leads to osteolytic lesions and generation of osteoclast-myeloma hybrid cells

Thomas L. Andersen

Thomas L. Andersen

Department of Clinical Cell Biology (KCB), Vejle Hospital, CSFU-IRS, University of Southern Denmark

Search for more papers by this author
Kent Søe

Kent Søe

Department of Clinical Cell Biology (KCB), Vejle Hospital, CSFU-IRS, University of Southern Denmark

Search for more papers by this author
Teis E. Sondergaard

Teis E. Sondergaard

Department of Clinical Cell Biology (KCB), Vejle Hospital, CSFU-IRS, University of Southern Denmark

Search for more papers by this author
Torben Plesner

Torben Plesner

Department of Hematology, Vejle Hospital, CSFU-IRS, University of Southern Denmark, Vejle, Denmark

Search for more papers by this author
Jean-Marie Delaisse

Jean-Marie Delaisse

Department of Clinical Cell Biology (KCB), Vejle Hospital, CSFU-IRS, University of Southern Denmark

Search for more papers by this author
First published: 25 January 2010
Citations: 64
Thomas L. Andersen, Department of Clinical Cell Biology (KCB), Vejle Hospital, IRS-CSFU, University of Southern Denmark, 7100 Vejle, Denmark. E-mail: [email protected]
Jean-Marie Delaisse, Department of Clinical Cell Biology (KCB), Vejle Hospital, IRS-CSFU, University of Southern Denmark, 7100 Vejle, Denmark. E-mail: [email protected]

The project was financially supported be the Danish Research Council and the Danish Cancer Society.

Summary

Osteolytic lesions are a hallmark of multiple myeloma. They are due to the hyperactivity of bone resorbing osteoclasts and hypoactivity of bone forming osteoblasts, in response to neighbouring myeloma cells. This study identified a structure that deeply affects this response, because of its impact on the physical organisation of the myeloma cell microenvironment. The proximity between myeloma cells and osteoclasts or osteoblasts was shown to be conditioned by the recently discovered layer of flat cells that separates the osteoclasts and osteoblasts from the bone marrow, by forming a canopy over bone remodelling compartment (BRC). These canopies are frequently disrupted in myeloma, and this disruption correlates with increased proximity and density of myeloma cells. In vitro evidence indicates that this disruption may be due to direct contact between myeloma and BRC canopy cells. Importantly, this disruption and increased proximity and density of myeloma cells coincides with key myeloma-induced bone events, such as osteolytic lesions, impaired bone formation despite increased bone resorption, and fusion of myeloma cells with osteoclasts thereby forming myeloma-osteoclast hybrid cells. These findings strongly support a critical role of BRC canopies in myeloma-induced bone disease. BRC canopies could therefore be considered as a new therapeutic target.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.